Why the study?
The study evaluated the role of NT-proBNP level as a predictor of progressive heart failure in patients with prediabetes during clinical observation.
Does elevated NT-proBNP level predict progressive heart failure and MACE in a patient with prediabetes?
Does elevated NT-proBNP level predict progressive heart failure and MACE in a patient with prediabetes?
Elevated NT-proBNP levels may help predict long-term risk of MACE and progressive heart failure in prediabetic patients without clinical HF, guiding proactive preventive measures.
Answers are grounded in this paper and cite their sources.
NT-proBNP may predict progressive HF in prediabetes; hypothesis-generating, requires confirmation before any practice change.
In the course of clinical observation over a two-year period the role of N-terminal prohormone of brain natriuretic peptide (NT-proBNP) level as a predictor of progressive heart failure in patients with prediabetes was estimated. Actually NT-proBNP is widely used in clinical medicine as diagnostic biomarkers of heart failure and cardiac dysfunction. In the clinical case in question NT-proBNP has demonstrated clinical predictive value for the patient’s prognosis. Initially elevated NT-proBNP levels could supposedly independently predict an increased long-term risk of major adverse cardiac events (MACE) in individuals with prediabetes without clinical manifestations of heart failure and may help identify those indicated for more proactive global preventive measures
No takes yet. Share an insight, caveat, or question.
Arabidze et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: